Drug · DIN 02526670
TRIKAFTA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 22, 2022; first marketed April 22, 2022.
- Drug Identification Number (DIN)
- 02526670
- Company (DIN owner)
- Vertex Pharmaceuticals (Canada) IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ivacaftor, tezacaftor and elexacaftor R07AX32
- Class
- Human
- Record last updated
- February 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELEXACAFTOR | 50 MG | |
| TEZACAFTOR | 25 MG | |
| IVACAFTOR | 37.5 MG | |
| IVACAFTOR | 75 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 20, 2022: NOC 27994Supplement to a New Drug Submission (SNDS) · Expansion of Indication age range. Addition of new strength.
Other DINs named TRIKAFTA
- DIN 02517140 · Marketed
- DIN 02542277 · Marketed
- DIN 02542285 · Marketed